Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report

INTRODUCTION: Serological detection of SARS-CoV-2-specific immunoglobulins G (IgG) and M (IgM) antibodies is becoming increasingly important in the management of the COVID-19 pandemic. METHODS: We report the first results of COVID-19 serological testing in Bosnia and Herzegovina on 2841 samples coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Ašić, Adna, Prguda-Mujić, Jasminka, Salihefendić, Lana, Bešić, Larisa, Ler, Daria, Čeko, Ivana, Hadžović-Džuvo, Almira, Jažić, Sead, Konjhodžić, Rijad, Marjanović, Damir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130482/
https://www.ncbi.nlm.nih.gov/pubmed/34025854
http://dx.doi.org/10.5114/aoms/134143
_version_ 1783694538471112704
author Ašić, Adna
Prguda-Mujić, Jasminka
Salihefendić, Lana
Bešić, Larisa
Ler, Daria
Čeko, Ivana
Hadžović-Džuvo, Almira
Jažić, Sead
Konjhodžić, Rijad
Marjanović, Damir
author_facet Ašić, Adna
Prguda-Mujić, Jasminka
Salihefendić, Lana
Bešić, Larisa
Ler, Daria
Čeko, Ivana
Hadžović-Džuvo, Almira
Jažić, Sead
Konjhodžić, Rijad
Marjanović, Damir
author_sort Ašić, Adna
collection PubMed
description INTRODUCTION: Serological detection of SARS-CoV-2-specific immunoglobulins G (IgG) and M (IgM) antibodies is becoming increasingly important in the management of the COVID-19 pandemic. METHODS: We report the first results of COVID-19 serological testing in Bosnia and Herzegovina on 2841 samples collected and analysed in 2 medical institutions in Sarajevo. Antibody detection was performed using commercially available kits. RESULTS: In the first cohort, 43 IgM-positive/IgG-negative and 16 IgM-positive/IgG-positive individuals were detected, corresponding to 3.41% of participants having developed antibodies. In the second cohort, 4.28% participants were found to be IgM-negative/IgG-positive. CONCLUSIONS: Our results suggest the need for population-wide serological surveying in Bosnia and Herzegovina.
format Online
Article
Text
id pubmed-8130482
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-81304822021-05-21 Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report Ašić, Adna Prguda-Mujić, Jasminka Salihefendić, Lana Bešić, Larisa Ler, Daria Čeko, Ivana Hadžović-Džuvo, Almira Jažić, Sead Konjhodžić, Rijad Marjanović, Damir Arch Med Sci Research Letter INTRODUCTION: Serological detection of SARS-CoV-2-specific immunoglobulins G (IgG) and M (IgM) antibodies is becoming increasingly important in the management of the COVID-19 pandemic. METHODS: We report the first results of COVID-19 serological testing in Bosnia and Herzegovina on 2841 samples collected and analysed in 2 medical institutions in Sarajevo. Antibody detection was performed using commercially available kits. RESULTS: In the first cohort, 43 IgM-positive/IgG-negative and 16 IgM-positive/IgG-positive individuals were detected, corresponding to 3.41% of participants having developed antibodies. In the second cohort, 4.28% participants were found to be IgM-negative/IgG-positive. CONCLUSIONS: Our results suggest the need for population-wide serological surveying in Bosnia and Herzegovina. Termedia Publishing House 2021-03-18 /pmc/articles/PMC8130482/ /pubmed/34025854 http://dx.doi.org/10.5114/aoms/134143 Text en Copyright: © 2021 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Research Letter
Ašić, Adna
Prguda-Mujić, Jasminka
Salihefendić, Lana
Bešić, Larisa
Ler, Daria
Čeko, Ivana
Hadžović-Džuvo, Almira
Jažić, Sead
Konjhodžić, Rijad
Marjanović, Damir
Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
title Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
title_full Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
title_fullStr Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
title_full_unstemmed Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
title_short Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
title_sort serological testing for sars-cov-2 in bosnia and herzegovina: first report
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130482/
https://www.ncbi.nlm.nih.gov/pubmed/34025854
http://dx.doi.org/10.5114/aoms/134143
work_keys_str_mv AT asicadna serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT prgudamujicjasminka serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT salihefendiclana serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT besiclarisa serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT lerdaria serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT cekoivana serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT hadzovicdzuvoalmira serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT jazicsead serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT konjhodzicrijad serologicaltestingforsarscov2inbosniaandherzegovinafirstreport
AT marjanovicdamir serologicaltestingforsarscov2inbosniaandherzegovinafirstreport

Ejemplares similares